• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pathologic Upstaging in Early-stage Non-small Cell Lung Cancer: Predictors and Clinical Impact of Sublobar Resection.

作者信息

de Ribot Anna, Muñoz Anna, Paradela Marina, Macía Iván, Rivas Francisco, Moreno Camilo, Serratosa Ines, García Marta, Martos Tania, Marcé Judith, Ojanguren Amaia, Déniz Carlos

机构信息

Barcelona University, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Thoracic Surgery Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

出版信息

Open Respir Arch. 2025 Apr 3;7(2):100434. doi: 10.1016/j.opresp.2025.100434. eCollection 2025 Apr-Jun.

DOI:10.1016/j.opresp.2025.100434
PMID:40475089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12139009/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4b/12139009/0816b278d5fe/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4b/12139009/0816b278d5fe/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd4b/12139009/0816b278d5fe/gr1.jpg

相似文献

1
Pathologic Upstaging in Early-stage Non-small Cell Lung Cancer: Predictors and Clinical Impact of Sublobar Resection.早期非小细胞肺癌的病理分期上调：肺叶下切除的预测因素及临床影响
Open Respir Arch. 2025 Apr 3;7(2):100434. doi: 10.1016/j.opresp.2025.100434. eCollection 2025 Apr-Jun.
2
Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation.胸外科医师协会数据库中肺叶切除术与肺段切除术的比较：患者因素和淋巴结评估的重要性
Ann Thorac Surg. 2025 May;119(5):1071-1081. doi: 10.1016/j.athoracsur.2025.01.004. Epub 2025 Jan 24.
3
Association of pre-surgical circulating tumor DNA detection, use of sublobar resection with risk of recurrence in stage I non-small cell lung cancer.I期非小细胞肺癌术前循环肿瘤DNA检测、亚肺叶切除的使用与复发风险的关联
Eur J Cancer. 2025 Feb 25;217:115237. doi: 10.1016/j.ejca.2025.115237. Epub 2025 Jan 13.
4
Sublobar resection versus definitive radiation in patients with stage IA non-small cell lung cancer.亚肺叶切除术与根治性放疗治疗ⅠA 期非小细胞肺癌的比较。
Ann Thorac Surg. 2012 Aug;94(2):354-60; discussion 360-1. doi: 10.1016/j.athoracsur.2011.12.092. Epub 2012 Mar 17.
5
Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.亚肺叶切除术治疗ⅠA 期非小细胞肺癌：术前 CT 特征在预测病理淋巴管血管侵犯和术后复发中的作用。
AJR Am J Roentgenol. 2021 Oct;217(4):871-881. doi: 10.2214/AJR.21.25618. Epub 2021 May 12.
6
Is Sublobar Resection Feasible for High-Risk Pathologic Stage I Non-small Cell Lung Cancer?亚肺叶切除术对高风险病理I期非小细胞肺癌是否可行？
Ann Surg Oncol. 2025 Jun;32(6):4161-4172. doi: 10.1245/s10434-024-16700-z. Epub 2024 Dec 16.
7
Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.临床ⅠA 期肺癌的长期结果：肺叶切除术与亚肺叶切除术比较。
Ann Thorac Surg. 2018 Aug;106(2):375-381. doi: 10.1016/j.athoracsur.2018.02.049. Epub 2018 Mar 23.
8
Pathologic Upstaging in Patients Undergoing Resection for Stage I Non-Small Cell Lung Cancer: Are There Modifiable Predictors?接受I期非小细胞肺癌切除术患者的病理分期上调：是否存在可改变的预测因素？
Ann Thorac Surg. 2015 Dec;100(6):2048-53. doi: 10.1016/j.athoracsur.2015.05.100. Epub 2015 Aug 13.
9
Lobectomy plus lobe-specific lymphadenectomy as the minimum standards of curative resection for hypermetabolic clinical stage IA non-small cell lung cancer.肺叶切除术加肺叶特异性淋巴结清扫术作为高代谢临床ⅠA期非小细胞肺癌根治性切除的最低标准。
Transl Lung Cancer Res. 2025 Jan 24;14(1):14-26. doi: 10.21037/tlcr-24-804. Epub 2025 Jan 22.
10
The prognosis of small-sized non-small cell lung cancer with visceral pleural invasion after sublobar resection.肺叶下切除术后伴有脏层胸膜侵犯的小尺寸非小细胞肺癌的预后
Transl Cancer Res. 2020 Oct;9(10):6431-6443. doi: 10.21037/tcr-20-1995.

本文引用的文献

1
Prognostic implication of methylation-based circulating tumor DNA detection prior to surgery in stage I non-small cell lung cancer.术前基于甲基化的循环肿瘤 DNA 检测对 I 期非小细胞肺癌的预后意义。
Cancer Lett. 2024 Jul 10;594:216984. doi: 10.1016/j.canlet.2024.216984. Epub 2024 May 24.
2
Circulomic variables predict pathologic staging preoperatively in treatment-naïve non-small cell lung cancer.循环组学变量可在未经治疗的非小细胞肺癌术前预测病理分期。
J Thorac Dis. 2023 Oct 31;15(10):5507-5516. doi: 10.21037/jtd-23-390. Epub 2023 Oct 20.
3
Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503).
亚肺叶切除术与肺叶切除术治疗早期非小细胞肺癌的围手术期死亡率和发病率：一项国际、随机、III 期试验（CALGB/Alliance 140503）的事后分析。
Lancet Respir Med. 2018 Dec;6(12):915-924. doi: 10.1016/S2213-2600(18)30411-9. Epub 2018 Nov 12.
4
Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.T1 N0 期非小细胞肺癌肺叶切除术与局限性切除术的随机试验。肺癌研究组
Ann Thorac Surg. 1995 Sep;60(3):615-22; discussion 622-3. doi: 10.1016/0003-4975(95)00537-u.